ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Colorectal Cancer

Endometrial Cancer trials near Sevilla, AN, ESP:

Maintenance with Selinexor/Placebo After Combination Chemotherapy in Participants with Endometrial Cancer [SIENDO] (ENGOT-EN5)

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Sevilla, Spain and 77 other locations

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...

Enrolling
Endometrial Cancer
Drug: Navtemadlin
Drug: Navtemadlin Placebo

Phase 2, Phase 3

Kartos Therapeutics
Kartos Therapeutics

Seville, Spain and 82 other locations

who have the appropriate human leukocyte antigen (HLA) and MAGE-A4 tumor antigen. Tumor indications include endometrial, e....

Enrolling
Endometrial Cancer
Esophageal Cancer
Genetic: Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks

Phase 1

Adaptimmune

Sevilla, Spain and 21 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Cisplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

Sevilla, Spain and 93 other locations

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....

Enrolling
Endometrial Cancer
Advanced Solid Tumor
Drug: CPI-0209

Phase 1, Phase 2

Constellation Pharmaceuticals

Seville, Spain and 59 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Jeréz De La Frontera, Cádiz, Spain and 123 other locations

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...

Enrolling
Endometrial Cancer
Drug: Matching Placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Sevilla, Spain and 165 other locations

or metastatic cancers....

Enrolling
Endometrial Cancer
Lung Neoplasms
Drug: CK-301 (cosibelimab)

Phase 1

Checkpoint Therapeutics

Sevilla, Spain and 47 other locations

Locations recently updated

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Enrolling
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Sevilla, Spain and 76 other locations

This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial ...

Enrolling
Recurrent or Metastatic Solid Tumors
Drug: Ifinatamab deruxtecan

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Sevilla, Spain and 105 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems